News

Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...
Aluminum-adsorbed vaccines were not associated with the development of chronic diseases in youth, according to a large study ...
An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used ...